Physician profile
Scott L Geller
NPI 1609858711
$618.09
in general payments reported to CMS, 2019-2025
11 companies · $55.49 in 2025
The $55.49 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.18 · 2021: $42.93 · 2022: $79.14 · 2023: $100 · 2024: $299 · 2025: $55.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $454.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $140.66 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Boston Scientific Corporation | $83.33 | 2024 | |
| Dompe US, INC. | $79.14 | 2022 | |
| Haag-Streit USA, INC. | $70.93 | 2023 | |
| Mallinckrodt Hospital Products INC. | $58.39 | 2021-2023 | Acthar |
| Biotissue Holdings INC. | $55.49 | 2025 | |
| Harrow Eye, LLC | $39.01 | 2024 | Iheezo, Triesence |
| Carl Zeiss Meditec, INC. | $36.11 | 2024 | |
| Mallinckrodt Enterprises LLC | $23.97 | 2019 | |
| Teleflex LLC | $17.21 | 2019 | |
| Allergan, INC. | $13.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Geller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.